GB9804861D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9804861D0
GB9804861D0 GBGB9804861.4A GB9804861A GB9804861D0 GB 9804861 D0 GB9804861 D0 GB 9804861D0 GB 9804861 A GB9804861 A GB 9804861A GB 9804861 D0 GB9804861 D0 GB 9804861D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9804861.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Medicine and Chemistry Inc
Original Assignee
Research Institute for Medicine and Chemistry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Medicine and Chemistry Inc filed Critical Research Institute for Medicine and Chemistry Inc
Priority to GBGB9804861.4A priority Critical patent/GB9804861D0/en
Publication of GB9804861D0 publication Critical patent/GB9804861D0/en
Priority to CNB998036935A priority patent/CN1177860C/zh
Priority to EP99937931A priority patent/EP1060188A1/en
Priority to ZA9901841A priority patent/ZA991841B/xx
Priority to PCT/GB1999/000681 priority patent/WO1999045024A1/en
Priority to AU32675/99A priority patent/AU752992B2/en
Priority to HU0100854A priority patent/HUP0100854A3/hu
Priority to NZ506139A priority patent/NZ506139A/xx
Priority to CA002319763A priority patent/CA2319763C/en
Priority to JP2000534566A priority patent/JP2002505336A/ja
Priority to KR1020007009596A priority patent/KR100690037B1/ko
Priority to CZ20003253A priority patent/CZ298478B6/cs
Priority to IL13813799A priority patent/IL138137A/xx
Priority to US09/630,546 priority patent/US7235552B1/en
Priority to NO20004399A priority patent/NO317378B1/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9804861.4A 1998-03-06 1998-03-06 Chemical compounds Ceased GB9804861D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB9804861.4A GB9804861D0 (en) 1998-03-06 1998-03-06 Chemical compounds
IL13813799A IL138137A (en) 1998-03-06 1999-03-08 Cholenic acid amides and pharmaceutical compositions thereof
HU0100854A HUP0100854A3 (en) 1998-03-06 1999-03-08 Cholenic acid amides, process for their preparation and pharmaceutical compositions thereof
CA002319763A CA2319763C (en) 1998-03-06 1999-03-08 Cholenic acid amides and pharmaceutical compositions thereof
ZA9901841A ZA991841B (en) 1998-03-06 1999-03-08 Chemical Compounds.
PCT/GB1999/000681 WO1999045024A1 (en) 1998-03-06 1999-03-08 Cholenic acid amides and pharmaceutical compositions thereof
AU32675/99A AU752992B2 (en) 1998-03-06 1999-03-08 Cholenic acid amides and pharmaceutical compositions thereof
CNB998036935A CN1177860C (zh) 1998-03-06 1999-03-08 胆烯酸酰胺及其药物组合物
NZ506139A NZ506139A (en) 1998-03-06 1999-03-08 Cholenic acid amides and pharmaceutical compositions thereof
EP99937931A EP1060188A1 (en) 1998-03-06 1999-03-08 Cholenic acid amides and pharmaceutical compositions thereof
JP2000534566A JP2002505336A (ja) 1998-03-06 1999-03-08 コレン酸アミドおよびその医薬組成物
KR1020007009596A KR100690037B1 (ko) 1998-03-06 1999-03-08 콜렌산 아미드 및 이를 함유하는 약학적 조성물
CZ20003253A CZ298478B6 (cs) 1998-03-06 1999-03-08 Sterolové deriváty a farmaceutické prostredky s jejich obsahem
US09/630,546 US7235552B1 (en) 1998-03-06 2000-08-01 Cholenic acid amides and pharmaceutical compositions thereof
NO20004399A NO317378B1 (no) 1998-03-06 2000-09-04 Kolensyreamider og farmasoytiske sammensetninger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804861.4A GB9804861D0 (en) 1998-03-06 1998-03-06 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9804861D0 true GB9804861D0 (en) 1998-04-29

Family

ID=10828156

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9804861.4A Ceased GB9804861D0 (en) 1998-03-06 1998-03-06 Chemical compounds

Country Status (15)

Country Link
US (1) US7235552B1 (cg-RX-API-DMAC10.html)
EP (1) EP1060188A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002505336A (cg-RX-API-DMAC10.html)
KR (1) KR100690037B1 (cg-RX-API-DMAC10.html)
CN (1) CN1177860C (cg-RX-API-DMAC10.html)
AU (1) AU752992B2 (cg-RX-API-DMAC10.html)
CA (1) CA2319763C (cg-RX-API-DMAC10.html)
CZ (1) CZ298478B6 (cg-RX-API-DMAC10.html)
GB (1) GB9804861D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0100854A3 (cg-RX-API-DMAC10.html)
IL (1) IL138137A (cg-RX-API-DMAC10.html)
NO (1) NO317378B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ506139A (cg-RX-API-DMAC10.html)
WO (1) WO1999045024A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA991841B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2408751A1 (en) * 2000-05-11 2001-11-15 Robert Henry Hesse 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
EP1514874A1 (en) * 2003-07-28 2005-03-16 Schering Aktiengesellschaft Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof
WO2009059239A2 (en) * 2007-11-02 2009-05-07 Mayo Foundation For Medical Education And Research REDUCING Aβ42 LEVELS AND Aβ AGGREGATION
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
US8987235B2 (en) 2011-05-17 2015-03-24 Wisconsin Alumni Research Foundation N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses
KR20140063616A (ko) 2011-07-20 2014-05-27 브라이엄 영 유니버시티 소수성 세라게닌 화합물 및 이를 포함하는 기구
BR112015023747B1 (pt) 2013-03-15 2023-04-18 Brigham Young University Uso de um composto antimicrobiano catiônico esteroide (csa) para a preparação de uma composição para tratar, reduzir, ou prevenir inflamação aguda ou crônica e/ou dor aguda ou crônica associada com uma doença ou um sintoma de doença
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
US9434759B1 (en) * 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
EP3275888B1 (en) * 2016-07-28 2019-09-25 Council of Scientific & Industrial Research Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
WO2023205801A2 (en) 2022-04-22 2023-10-26 Asteroid Therapeutics Steroidal compositions and methods of treating lipogenic cancers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1512326A (fr) 1964-03-27 1968-02-09 Roussel Uclaf Nouveaux stéroïdes azotés et procédé de préparation
US4217288A (en) * 1977-03-24 1980-08-12 Wisconsin Alumni Research Foundation Anti-vitamin D compounds
US4172076A (en) * 1977-04-04 1979-10-23 Diamond Shamrock Corporation Process for preparing steroidal acids and their intermediate derivatives
FR2426044A2 (fr) * 1978-05-19 1979-12-14 Wisconsin Research Foundation Derives de la vitamine d3 ayant une activite anti-vitamine d
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
PL171580B1 (pl) * 1991-11-07 1997-05-30 Res Inst Medicine Chem Sposób wytwarzania nowych analogów witaminy D3 PL PL PL
JP3493037B2 (ja) * 1991-12-18 2004-02-03 中外製薬株式会社 22−オキサコレカルシフェロール誘導体とその製造方法
IL105050A0 (en) * 1992-03-27 1993-07-08 Lilly Co Eli Steroid derivatives
GB9309422D0 (en) * 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
WO1997042215A1 (en) * 1996-05-06 1997-11-13 Bionumerik Pharmaceuticals, Inc. Process for preparing 27-hydroxy cholesterol and related derivatives
EP1019059A4 (en) * 1997-01-24 2004-01-14 Univ California USE OF FXR, PPAR-ALPHA AND LXR-ALPHA ACTIVATORS TO RESTORE THE BARRIER FUNCTION, TO PROMOTE EPIDERMIS DIFFERENTIATION, AND TO PROLIFERATE

Also Published As

Publication number Publication date
NO20004399D0 (no) 2000-09-04
CA2319763A1 (en) 1999-09-10
CN1177860C (zh) 2004-12-01
KR100690037B1 (ko) 2007-03-08
ZA991841B (en) 1999-09-08
HUP0100854A3 (en) 2002-09-30
KR20010041446A (ko) 2001-05-25
CZ298478B6 (cs) 2007-10-17
AU3267599A (en) 1999-09-20
WO1999045024A1 (en) 1999-09-10
IL138137A0 (en) 2001-10-31
HUP0100854A2 (hu) 2001-09-28
AU752992B2 (en) 2002-10-03
EP1060188A1 (en) 2000-12-20
CA2319763C (en) 2008-01-15
IL138137A (en) 2005-11-20
CZ20003253A3 (cs) 2001-03-14
NO20004399L (no) 2000-11-03
NZ506139A (en) 2003-06-30
NO317378B1 (no) 2004-10-18
CN1292797A (zh) 2001-04-25
JP2002505336A (ja) 2002-02-19
US7235552B1 (en) 2007-06-26

Similar Documents

Publication Publication Date Title
GB9800428D0 (en) Chemical compounds
GB9812709D0 (en) Chemical compounds
GB9813565D0 (en) Chemical compounds
GB9811159D0 (en) Chemical compounds
GB9816654D0 (en) Chemical compounds
GB9812088D0 (en) Chemical compounds
GB9804343D0 (en) Chemical compounds
GB9801812D0 (en) Chemical compounds
GB9818641D0 (en) Chemical compounds
GB9802028D0 (en) Chemical compounds
GB9809161D0 (en) Chemical compounds
GB9814276D0 (en) Chemical compounds
GB9818981D0 (en) Chemical compounds
GB9818979D0 (en) Chemical compounds
GB9804161D0 (en) Chemical compounds
GB9805498D0 (en) Chemical compounds
GB9806309D0 (en) Chemical compounds
GB9802066D0 (en) Chemical compounds
GB9815973D0 (en) Chemical compounds
GB9802762D0 (en) Chemical compounds
GB9807576D0 (en) Chemical compounds
GB9813736D0 (en) Chemical compounds
GB9816194D0 (en) Chemical compounds
GB9816116D0 (en) Chemical compounds
GB9800396D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)